Bolayir K, Gökşin N
Department of Urology, State Hospital North-Cyprus.
Acta Chir Hung. 1994;34(3-4):253-6.
In the years 1992-1993 40 impotent men received treatment with a combination of papaverine and verapamil as intracavernous self-injection (ISPV). Patients' age was between 40 and 75 years. Average injection doses were 5 mg verapamil and 20 mg papaverine. Among those patients no priapism was encountered. Scarring was documented in one patient. Combination therapy is reliable, well accepted and applicable with minimum local risks in erectile dysfunction men.
在1992年至1993年期间，40名阳痿男性接受了罂粟碱和维拉帕米联合海绵体内自我注射（ISPV）治疗。患者年龄在40至75岁之间。平均注射剂量为5毫克维拉帕米和20毫克罂粟碱。在这些患者中未出现阴茎异常勃起。有一名患者记录有瘢痕形成。联合治疗可靠、易于接受，且对勃起功能障碍男性的局部风险最小。
